Advertisements

Bristol Myers to pay bluebird $200 million for future royalties on cancer therapies

Bristol Myers to pay bluebird $200 million for future royalties on cancer therapies.....»»

Category: global-financeSource: reutersMay 11th, 2020

U.S. FDA declines to review Bristol Myers, bluebird therapy for multiple myeloma

U.S. FDA declines to review Bristol Myers, bluebird therapy for multiple myeloma.....»»

Category: global-financeSource: reutersMay 13th, 2020

U.S. FDA extends review of Bristol Myers" cancer therapy acquired in Celgene deal

U.S. FDA extends review of Bristol Myers" cancer therapy acquired in Celgene deal.....»»

Category: global-financeSource: reutersMay 6th, 2020

Dr Reddy#39;s launches generic cancer drug in India

Dr Reddy#39;s launches generic cancer drug in India.....»»

Category: topSource: moneycontrolApr 13th, 2020

Bristol-Myers has Opdivo lung cancer setback as sales beat estimates

Bristol-Myers has Opdivo lung cancer setback as sales beat estimates.....»»

Category: global-financeSource: reutersJan 24th, 2019

Bristol-Myers to buy Celgene for $74 billion in largest biopharma deal

Bristol-Myers to buy Celgene for $74 billion in largest biopharma deal.....»»

Category: global-financeSource: reutersJan 3rd, 2019

Bristol-Myers bulks up with $74 billion deal to buy Celgene

Bristol-Myers bulks up with $74 billion deal to buy Celgene.....»»

Category: global-financeSource: reutersJan 3rd, 2019

Bristol-Myers bulks up cancer portfolio with $74 billion Celgene deal

Bristol-Myers bulks up cancer portfolio with $74 billion Celgene deal.....»»

Category: global-financeSource: reutersJan 3rd, 2019

Bristol-Myers beefs up cancer portfolio with $74 billion Celgene buy

Bristol-Myers beefs up cancer portfolio with $74 billion Celgene buy.....»»

Category: global-financeSource: reutersJan 3rd, 2019

Merck profit beats, but Keytruda sales fail to impress

Merck profit beats, but Keytruda sales fail to impress.....»»

Category: global-financeSource: reutersJul 27th, 2018

Bristol-Myers cancer ruling hits shares after strong earnings

Bristol-Myers cancer ruling hits shares after strong earnings.....»»

Category: global-financeSource: reutersJul 26th, 2018

Bristol-Myers profit tops Street view, raises full-year forecast

Bristol-Myers profit tops Street view, raises full-year forecast.....»»

Category: global-financeSource: reutersJul 26th, 2018

Bristol-Myers second-quarter earnings rise, full-year forecast up on strong sales

Bristol-Myers second-quarter earnings rise, full-year forecast up on strong sales.....»»

Category: global-financeSource: reutersJul 26th, 2018

Merck, Bristol-Myers immunotherapies impress in key lung cancer trials

Merck, Bristol-Myers immunotherapies impress in key lung cancer trials.....»»

Category: global-financeSource: reutersApr 16th, 2018

US STOCKS-Industrials, techs lift Wall St, health stocks limit gains

US STOCKS-Industrials, techs lift Wall St, health stocks limit gains.....»»

Category: marketsSource: sifyNov 20th, 2017

US STOCKS-Tech stocks help Wall Street higher

US STOCKS-Tech stocks help Wall Street higher.....»»

Category: economySource: sifyNov 20th, 2017

Bristol Myers" treatment succeeds in late-stage bowel disease study

Bristol Myers" treatment succeeds in late-stage bowel disease study.....»»

Category: global-financeSource: reutersJun 2nd, 2020

Israel"s OurCrowd to raise $100 million for coronavirus technologies

Israel"s OurCrowd to raise $100 million for coronavirus technologies.....»»

Category: global-financeSource: reutersJun 2nd, 2020

Bristol Myers sees 2020 earnings holding despite coronavirus pandemic

Bristol Myers sees 2020 earnings holding despite coronavirus pandemic.....»»

Category: global-financeSource: reutersMay 7th, 2020

Apple#39;s WWDC 2020 to start from June 22, to be held virtually for the first time due to COVID-19

Apple#39;s WWDC 2020 to start from June 22, to be held virtually for the first time due to COVID-19.....»»

Category: infotechSource: moneycontrolMay 5th, 2020

Coronavirus pandemic leads big drugmakers to hit pause on clinical trials

Coronavirus pandemic leads big drugmakers to hit pause on clinical trials.....»»

Category: global-financeSource: reutersMar 23rd, 2020